Target intelligence / Profile preview

Interleukin-23 (IL-23)

Target
IL-23
Molecular classification
Cytokine, Interleukin-12 family
01

Overview

Interleukin-23 (IL-23) is a pro-inflammatory cytokine belonging to the IL-12 family. It plays a central role in immune system regulation, particularly in bridging innate and adaptive immunity and driving inflammatory responses. IL-23 is primarily produced by activated dendritic cells, macrophages, monocytes, and to some extent by B cells and other immune cell types upon antigenic stimulation. IL-23 is a heterodimeric protein composed of two subunits: p19 (unique to IL-23) and p40 (shared with interleukin 12 (IL-12)). It is a therapeutic target, particularly for autoimmune and inflammatory diseases, with therapies targeting either the cytokine itself or its receptor.

02

Mechanism of action

Therapeutic antibodies bind to IL-23, preventing its interaction with the IL-23 receptor, thereby inhibiting downstream signaling and inflammatory responses.

03

Biological functions

Maintenance/expansion of Th17 cellsActivation/proliferation of CD4+ memory T cellsStimulation/enhancement of natural killer cell functionPromotion of angiogenesisRegulation/modulation within barrier tissuesImmune response
04

Disease associations

PsoriasisInflammatory bowel diseaseRheumatoid arthritisMultiple sclerosisCancerInflammationAutoimmune diseases
05

Safety considerations

Increased risk of infectionPotential for paradoxical inflammatory responsesLong-term effects on immune system homeostasis
06

Biomarkers

IL-23 levels in serum/tissueExpression of IL-23-responsive genes in immune cells

Beyond the preview

Go deeper on Interleukin-23 (IL-23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interleukin-23 (IL-23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call